Meta-analysis finds bright light therapy boosts remission and response in nonseasonal depression, offering a low-cost add-on to standard care.
|Articles|August 11, 2017
Which Came First: Fatigue or Depression?
Author(s)Steven D. Targum, MD
5 key questions to ask as part of a comprehensive differential assessment of fatigue and depression.
Advertisement
The onset of some fatigue symptoms may suggest an emerging illness and often occurs as part of a medical and/or psychiatric disorder. Here are 5 key questions to ask as part of a comprehensive differential assessment of fatigue and depression.
For the full article on which this video is based, as well as the free CME post-test, see
Advertisement
Related to this article
Mixed-feature depression can signal bipolar risk; spot red flags and consider lurasidone or lumateperone before standard antidepressants.
Compass Pathways has completed its submission of an NDA to the FDA for COMP360 psilocybin for treatment-resistant depression.
GLP-1 drugs enter psychiatry, curbing antipsychotic weight gain while raising new questions about addiction, mood, eating disorders, and culture.
Alkermes launches a phase 2 trial of oral orexin-2 agonist ALKS 7290 to boost antidepressant response in major depressive disorder, assessing safety and symptom relief.
Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Shelves Fast-Track Drug Review Initiative
2
Scams: What Psychiatrists Need to Know
3
Reviewing Roluperidone as Treatment for Negative Symptoms in Schizophrenia
4
Major Depressive Disorder With Mixed Features: Diagnosis and Treatment
5